Capricor Therapeutics (CAPR) Institutional Ownership → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free CAPR Stock Alerts $6.20 +0.56 (+9.93%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$2.24MNumber ofInstitutional Sellers(last 12 months)0 Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Ad InvestorPlaceElon Musk’s PRIME is Set to Shock the WorldMust-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing.Click here for the full story… Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 Vanguard Group Inc.1,365,903$9.27M0.0%+17.2%4.336% 5/1/2024 BNP Paribas Financial Markets5,827$40K0.0%N/A0.018% 2/7/2024 Jump Financial LLC52,800$258K0.0%N/A0.171% 12/6/2023 Citigroup Inc.61,591$211K0.0%N/A0.200% 7/31/2023 LPL Financial LLC78,436$375K0.0%N/A0.310% 5/1/2023Virtu Financial LLC16,895$71K0.0%N/A0.067% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022 Jump Financial LLC22,600$136K0.0%N/A0.093% 10/18/2022 Bailard Inc.33,601$202K0.0%+12.8%0.138% 7/27/2022 Bailard Inc.29,801$104K0.0%N/A0.123% 4/20/2022 Selective Wealth Management Inc.213,494$732K0.3%N/A0.878% 11/16/2021 Two Sigma Securities LLC11,511$46K0.0%N/A0.050% 11/15/2021 GSA Capital Partners LLP96,632$388K0.0%-14.0%0.420% 11/15/2021 HighTower Advisors LLC53,960$215K0.0%+206.6%0.234% 11/9/2021 Barclays PLC6,330$25K0.0%+246.1%0.027% 11/9/2021 BlackRock Inc.300,201$1.21M0.0%-1.6%1.304% 8/17/2021 Oracle Investment Management Inc.1,166,249$5.98M0.8%-41.7%5.098% 8/16/2021 State Street Corp71,748$368K0.0%N/A0.314% 8/13/2021 Northern Trust Corp104,251$535K0.0%+7.5%0.456% 8/13/2021 Geode Capital Management LLC184,990$948K0.0%+7.9%0.809% 8/13/2021 Vanguard Group Inc.923,233$4.74M0.0%+1.2%4.035% 8/11/2021Susquehanna Fundamental Investments LLC16,500$85K0.0%-49.1%0.072% 8/5/2021 GSA Capital Partners LLP112,364$576K0.1%+684.6%0.491% 5/18/2021 Millennium Management LLC22,390$105K0.0%-54.6%0.098% 5/18/2021 Oracle Investment Management Inc.1,999,464$9.36M1.4%N/A8.770% 5/12/2021 Northern Trust Corp96,941$453K0.0%-29.1%0.425% 5/12/2021 M Holdings Securities Inc.20,000$94K0.0%N/A0.088% 5/12/2021 Geode Capital Management LLC171,415$802K0.0%+40.7%0.752% 5/10/2021 HighTower Advisors LLC12,300$57K0.0%-25.9%0.054% 5/10/2021 GSA Capital Partners LLP14,321$67K0.0%-81.9%0.063% 5/7/2021 BlackRock Inc.347,103$1.62M0.0%+1.2%1.523% 5/3/2021Trellus Management Company LLC270,000$1.26M0.7%N/A1.184% 2/11/2021 Northern Trust Corp136,814$469K0.0%-9.6%0.669% 2/9/2021 Bank of New York Mellon Corp89,249$306K0.0%+47.7%0.436% 2/5/2021 BlackRock Inc.343,011$1.18M0.0%+0.4%1.677% 2/4/2021 GSA Capital Partners LLP79,091$271K0.0%N/A0.387% 11/17/2020 Jane Street Group LLC12,943$68K0.0%-51.1%0.066% 11/13/2020 Morgan Stanley44,843$235K0.0%+26.4%0.227% 11/12/2020 JPMorgan Chase & Co.5,607$30K0.0%+80,000.0%0.028% 11/6/2020 BlackRock Inc.341,523$1.79M0.0%+900.8%1.732% 9/15/2020 Two Sigma Advisers LP21,130$97K0.0%N/A0.107% Millionaire Investor makes surprising election prediction (Ad)Millionaire Investor Makes Surprising Election Prediction Louis Navellier says he knows who's going to win the election. And how they could send six specific AI stocks through the roof on their first day.Click here for the full story…8/17/2020 Jane Street Group LLC26,474$122K0.0%+9.6%0.134% 8/12/2020 Goldman Sachs Group Inc.38,808$179K0.0%N/A0.272% 8/10/2020 HighTower Advisors LLC13,000$59K0.0%N/A0.091% 8/7/2020Virtu Financial LLC57,444$264K0.0%N/A0.403% 5/15/2020 Jane Street Group LLC24,150$29K0.0%N/A0.194% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, the following institutional investors and hedge funds held shares of Capricor Therapeutics shares: Vanguard Group Inc. ($9.27M), LPL Financial LLC ($375K), Jump Financial LLC ($258K), Citigroup Inc. ($211K), Bailard Inc. ($202K), and Virtu Financial LLC ($71K), and BNP Paribas Financial Markets ($40K).Learn more on CAPR's institutional investors. What percentage of Capricor Therapeutics stock is owned by institutional investors? 21.68% of Capricor Therapeutics stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics stock? The following institutional investors have purchased Capricor Therapeutics stock in the last 24 months: Vanguard Group Inc. ($200.50K), LPL Financial LLC ($78.44K), Jump Financial LLC ($75.40K), Citigroup Inc. ($61.59K), Bailard Inc. ($33.60K), Virtu Financial LLC ($16.90K), and BNP Paribas Financial Markets ($5.83K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 472,249 shares in the last 24 months. This purchase volume represents approximately $2.58M in transactions. Related Companies: PRLD Institutional Ownership SCPH Institutional Ownership GOSS Institutional Ownership PRQR Institutional Ownership RIGL Institutional Ownership RPTX Institutional Ownership ALIM Institutional Ownership CRVO Institutional Ownership GLSI Institutional Ownership GALT Institutional Ownership This page (NASDAQ:CAPR) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersProtect Your Bank Account Before It’s Too LateWeiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.